<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteOrgans on Chips &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Fri, 15 May 2026 14:24:10 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/technology-area/organs-on-chips/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>Next-Gen Toxicology: Inside the Organ Chip Revolution with Donald Ingber</title>
				<link>https://wyss.harvard.edu/media-post/next-gen-toxicology-inside-the-organ-chip-revolution-with-donald-ingber/</link>
        <pubDate>Wed, 06 May 2026 17:06:35 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=45389</guid>
                                                <content:encoded><![CDATA[<p>In this episode of ToxChats, hosts Lauren Walker and Sarah Benjamin sit down with the groundbreaking Donald Ingber&mdash;visionary scientist, engineer, and Founding Director of the Wyss Institute. Ingber shares how his unique path through medicine, biology, and design converged to spark breakthroughs such as human Organ Chips&mdash;systems that are redefining toxicology, drug development, and disease modeling.</p>
<p><a href="https://wyss.harvard.edu/media-post/next-gen-toxicology-inside-the-organ-chip-revolution-with-donald-ingber/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/next-gen-toxicology-inside-the-organ-chip-revolution-with-donald-ingber/</link>
          <title>Founding Director Donald Ingber. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/05095242/Donald_Ingber_headshot_1500x1000.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=f86daa58baa3ae0c80720f0ca99dc64a"/></url>
				</image>
        			</item>

		
			<item>
				<title>20-ish Questions with Donald E. Ingber</title>
				<link>https://wyss.harvard.edu/media-post/20-ish-questions-with-donald-e-ingber/</link>
        <pubDate>Fri, 01 May 2026 12:00:26 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=45288</guid>
                                                <content:encoded><![CDATA[<p>20&#x2d;ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Donald E. Ingber, the Founding Director and a Core Faculty member at the Wyss Institute. He is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children&rsquo;s Hospital, as well as the&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/20-ish-questions-with-donald-e-ingber/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/20-ish-questions-with-donald-e-ingber/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/04/16114014/THUMBNAIL_20-ish-Questions-with-Don-Ingber_No-Text-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=9411b022404b9cf8eb8c9560744418dd"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute technologies enable breakthrough in astronaut health research aboard NASA’s Artemis II mission</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-technologies-enable-breakthrough-in-astronaut-health-research-aboard-nasas-artemis-ii-mission/</link>
        <pubDate>Thu, 09 Apr 2026 14:55:20 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[BARDA]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[NASA]]></category>
		<category><![CDATA[Stem Cells]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45228</guid>
                            <description>Wyss Institute-enabled Organ Chip “avatars” will provide insights into astronaut health risks and provide a tool for future discovery of countermeasures necessary for travel to the Moon and beyond</description>
                                        <content:encoded><![CDATA[<p>By Alexandra Jirstrand (BOSTON) &ndash; Launched on April 1, 2026, Artemis II is a historic, approximately 10&#x2d;day lunar flyby mission that is sending four astronauts farther into space than any humans have traveled since the Apollo era, marking a critical step toward sustained lunar exploration and future missions to Mars. The Wyss Institute for Biologically Inspired Engineering at Harvard&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-technologies-enable-breakthrough-in-astronaut-health-research-aboard-nasas-artemis-ii-mission/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-technologies-enable-breakthrough-in-astronaut-health-research-aboard-nasas-artemis-ii-mission/</link>
          <title>Using Organ Chips containing astronaut cells, Wyss Institute and Emulate researchers will examine how radiation and microgravity impact human tissue. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/04/08174051/NASA-Bonemarrow-Chips-03480_Chip-on-Microscope-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1f2bbd476766a3827d203d14fedb5a30"/></url>
				</image>
        			</item>

		
			<item>
				<title>Building protection against infectious diseases with nanostructured vaccines</title>
				<link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
        <pubDate>Wed, 11 Mar 2026 12:56:44 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Technology Translation]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45012</guid>
                            <description>Wyss Institute’s DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against infectious viruses</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The COVID&#x2d;19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID&#x2d;19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID&#x2d;19 in the first year alone.</p>
<p><a href="https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/10/19140258/banner-image-DoriVac.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=02c46a8a5e23e0c41c361cb65f4eb81c"/></url>
				</image>
        			</item>

		
			<item>
				<title>AVATARs for Astronaut Health Are Heading to Space!</title>
				<link>https://wyss.harvard.edu/media-post/avatars-for-astronaut-health-are-heading-to-space/</link>
        <pubDate>Thu, 05 Feb 2026 15:04:20 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=44790</guid>
                                                <content:encoded><![CDATA[<p>NASA&rsquo;s AVATAR experiment is flying aboard Artemis II to study how deep space affects human health. Using Organ Chips containing astronaut cells, Emulate and Wyss Institute researchers will examine how radiation and microgravity impact human tissue. This research will help inform medical strategies for future long&#x2d;duration missions to Mars and beyond. The findings could also contribute to&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/avatars-for-astronaut-health-are-heading-to-space/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/avatars-for-astronaut-health-are-heading-to-space/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/03/15123125/Organ-Chip-282A6210.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=8bef5a92861dbb7abfb350f987d9d561"/></url>
				</image>
        			</item>

		
			<item>
				<title>Transforming cancer treatments through bioinspired engineering and translation</title>
				<link>https://wyss.harvard.edu/news/transforming-cancer-treatments-through-bioinspired-engineering-and-translation/</link>
        <pubDate>Wed, 04 Feb 2026 14:59:03 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[ARPA-H]]></category>
		<category><![CDATA[Blood clotting]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
		<category><![CDATA[RNA]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44742</guid>
                                                <content:encoded><![CDATA[<p>Despite major advances in personalized medicine, targeted drugs, and immunotherapies, many cancers remain difficult &ndash; or impossible &ndash; to treat. Even when therapies work, they can trigger serious secondary health risks that may themselves become life&#x2d;threatening. Wyss Institute researchers are tackling these challenges head&#x2d;on by developing new therapies that more powerfully activate the immune&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/transforming-cancer-treatments-through-bioinspired-engineering-and-translation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/transforming-cancer-treatments-through-bioinspired-engineering-and-translation/</link>
          <title>Abidemi Junaid holding the microfluidic chip used to monitor blood clotting.</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/09145422/Abidemi-with-Hemostasis-Chip-Posed-08089-scaled.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=799ada1f03931c9e36620cd1d4f32f2f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Toward engineering a human kidney collecting duct system</title>
				<link>https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/</link>
        <pubDate>Fri, 30 Jan 2026 14:50:56 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Healthy Aging]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44698</guid>
                            <description>Newly developed method to fabricate perfusable collecting ducts of the human kidney opens the door to disease modeling, drug testing, and organ engineering </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The human kidney filters about a cup of blood every minute, removing waste, excess fluid, and toxins from it, while also regulating blood pressure, balancing important electrolytes, activating Vitamin D, and helping the body produce red blood cells. This broad range of functions is achieved in part via the kidney&rsquo;s complex organization. In its outer region&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/</link>
          <title>As can be seen in this close-up, engineered UB tubules bud from the central channel and branch into the surrounding matrix. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/01/27145033/Budding-UB-tubules-copy.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=89285f076bfcbe6edbe7343007eba2bb"/></url>
				</image>
        			</item>

		
			<item>
				<title>Organs on Chips: Using Science, Art, and Design to Understand the Human Body &#8211; Talking About Blood</title>
				<link>https://wyss.harvard.edu/media-post/organs-on-chips-using-science-art-and-design-to-understand-the-human-body-talking-about-blood/</link>
        <pubDate>Thu, 20 Nov 2025 18:41:34 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=44327</guid>
                                                <content:encoded><![CDATA[<p>In this episode, Wyss Founding Director Don Ingber, M.D., Ph.D., talks with Helen Osborne about: How organ&#x2d;on&#x2d;chip and &ldquo;human body on chips&rdquo; technologies are built and how they realistically mimic human organ function by combining living cells, blood flow, and mechanical forces like breathing and stretch; The implications of these chips for hematology and clinical care&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/organs-on-chips-using-science-art-and-design-to-understand-the-human-body-talking-about-blood/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/organs-on-chips-using-science-art-and-design-to-understand-the-human-body-talking-about-blood/</link>
          <title>Founding Director Donald Ingber. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/05095242/Donald_Ingber_headshot_1500x1000.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=f86daa58baa3ae0c80720f0ca99dc64a"/></url>
				</image>
        			</item>

		
			<item>
				<title>Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies</title>
				<link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
        <pubDate>Wed, 15 Oct 2025 13:55:54 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Lung-on-a-chip]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
		<category><![CDATA[Pathogen]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43920</guid>
                            <description>Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &ndash; The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally updated vaccines, IAV infections still lead to 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths annually. The development of antiviral treatments against IAV&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
          <title>New findings show that future pan-influenza A vaccines based on CRISPR technology can be preclinically assessed in human Organ Chips. Credit: Envato Elements/dvatri</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/10/14105510/portrait-of-a-family-activities-at-home-2025-09-14-16-44-58-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c1f3463c4436feb34fe1078d4163cfb9"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute receives Wellcome Leap funding to develop first Human Organ Chip model for heavy menstrual bleeding</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-receives-wellcome-leap-funding-to-develop-first-human-organ-chip-model-for-heavy-menstrual-bleeding/</link>
        <pubDate>Fri, 19 Sep 2025 13:55:11 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Women's Health Initiative]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43713</guid>
                            <description>Breakthrough aims to shorten the time women wait for effective treatment from an average of five years to just five months</description>
                                        <content:encoded><![CDATA[<p>By Alexandra Jirstrand (BOSTON) &ndash; The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded funding from Wellcome Leap&rsquo;s $50 million The Missed Vital Sign program, which seeks to transform how menstruation is understood and treated in healthcare. The Wyss will use its pioneering Organ Chip technology to create the first human model of heavy menstrual&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-receives-wellcome-leap-funding-to-develop-first-human-organ-chip-model-for-heavy-menstrual-bleeding/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-receives-wellcome-leap-funding-to-develop-first-human-organ-chip-model-for-heavy-menstrual-bleeding/</link>
          <title>Organ-on-a-Chip, 2009; Designed by Donald Ingber (American, b. 1956) and Dongeun Huh (Korean, b. 1975); Microfabricated device composed of silicone rubber; 3.5 × 0.5 × 2 cm (1 3/8 x 13/16  x 13/16 in.); Courtesy of Wyss Institute
for Biologically Inspired Engineering at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2019/07/09101926/Lung-on-a-Chip-illuminated-by-natural-light.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c4df4d44285d62ca9d168bda6059e4fe"/></url>
				</image>
        			</item>

			</channel>
</rss>
